Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes Trial.

Saved in:
Bibliographic Details
Title: Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes Trial.
Authors: Nicholls SJ; Victorian Heart Institute, Monash University, 631 Blackburn Road, Clayton, VIC, 3168, Australia. stephen.nicholls@monash.edu., Ray KK; Imperial College London, London, UK., Lincoff AM; Cleveland Clinic, Cleveland, OH, USA., Sarnes E; Esperion Therapeutics, Ann Arbor, MI, USA., Gillard KK; Esperion Therapeutics, Ann Arbor, MI, USA., Bloedon L; Esperion Therapeutics, Ann Arbor, MI, USA., Migliaccio-Walle K; Curta Inc., Seattle, WA, USA., Elsea D; Curta Inc., Seattle, WA, USA., Nissen SE; Cleveland Clinic, Cleveland, OH, USA.
Source: American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2026 Jan; Vol. 26 (1), pp. 59-70. Date of Electronic Publication: 2025 Aug 20.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100967755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-187X (Electronic) Linking ISSN: 11753277 NLM ISO Abbreviation: Am J Cardiovasc Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40833562
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nicholls+SJ%22">Nicholls SJ</searchLink>; Victorian Heart Institute, Monash University, 631 Blackburn Road, Clayton, VIC, 3168, Australia. stephen.nicholls@monash.edu.<br /><searchLink fieldCode="AU" term="%22Ray+KK%22">Ray KK</searchLink>; Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Lincoff+AM%22">Lincoff AM</searchLink>; Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Sarnes+E%22">Sarnes E</searchLink>; Esperion Therapeutics, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Gillard+KK%22">Gillard KK</searchLink>; Esperion Therapeutics, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Bloedon+L%22">Bloedon L</searchLink>; Esperion Therapeutics, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Migliaccio-Walle+K%22">Migliaccio-Walle K</searchLink>; Curta Inc., Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Elsea+D%22">Elsea D</searchLink>; Curta Inc., Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Nissen+SE%22">Nissen SE</searchLink>; Cleveland Clinic, Cleveland, OH, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100967755%22">American journal of cardiovascular drugs : drugs, devices, and other interventions</searchLink> [Am J Cardiovasc Drugs] 2026 Jan; Vol. 26 (1), pp. 59-70. <i>Date of Electronic Publication: </i>2025 Aug 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>100967755 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-187X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211753277%22">11753277 </searchLink><i>NLM ISO Abbreviation: </i>Am J Cardiovasc Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40833562
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40256-025-00753-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 59
    Titles:
      – TitleFull: Cost-Effectiveness of Bempedoic Acid in High Cardiovascular Risk Patients with Statin Intolerance: An Analysis of the CLEAR Outcomes Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nicholls SJ
      – PersonEntity:
          Name:
            NameFull: Ray KK
      – PersonEntity:
          Name:
            NameFull: Lincoff AM
      – PersonEntity:
          Name:
            NameFull: Sarnes E
      – PersonEntity:
          Name:
            NameFull: Gillard KK
      – PersonEntity:
          Name:
            NameFull: Bloedon L
      – PersonEntity:
          Name:
            NameFull: Migliaccio-Walle K
      – PersonEntity:
          Name:
            NameFull: Elsea D
      – PersonEntity:
          Name:
            NameFull: Nissen SE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-187X
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: American journal of cardiovascular drugs : drugs, devices, and other interventions
              Type: main
ResultId 1